NUOVE MOLECOLE CHEMIOTERAPICHE PER IL TRATTAMENTO DEI LINFOMI DEL SNC PRIMITIVI E SECONDARI Luciana Annino.
Nuclear medicine in systemic lymphomas
Overview of Lymphomas Jessica Hals, DO June 16 th 2005 Jessica Hals, DO June 16 th 2005.
CANCER CHEMOTHERAPY (Lecture Outline For Medical Students) 管 忠 震.
Update on the biology and risk- adapted CLL management in 2013 and the prospect of novel therapies Sami N. Malek, MD Associate Professor Department of.
Rituximab in aggressive NHL: why combination therapy should not be delayed
Goals Understand the differences between Hodgkin Lymphoma and non-Hodgkin Lymphoma –Clinically and biologically Understand the differences between aggressive.
GRADO INTERMEDIO Dfollicolare, prevalenza di grandi cellule Ediffuso, a piccole cellule clivate Fdiffuso, misto a piccole e grandi cellule
ROLE OF FDG-PET/CT STUDY IN THE DETECTION OF BONE MARROW DISEASE IN PATIENTS WITH AGGRESSIVE NON-HODGKIN LYMPHOMA (NHL) AND HODGKIN LYMPHOMA (HL)
